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Abstract
We have characterised G protein and fatty acid regulation of the Naq conductance in purified apical membrane vesicles
prepared from late gestation fetal guinea-pig lung. Addition of 100 mM GTPg S or bg-methylene-GTP, irreversible G
22 q protein activators, stimulated conductive Na uptake ratio of experimental to control 1.35"0.02 and 1.34"0.05,
. 22 qrespectively . Conversely, the addition of GDPb S, an irreversible G protein inhibitor, reduced conductive Na uptake
 .  .  .from 1.00 control to 0.79"0.04. A range of saturated myristic, palmitic, stearic , monounsaturated elaidic, oleic and
 . 22 qpolyunsaturated linoleic, arachidonic fatty acids all stimulated conductive Na uptake, by between 1.18"0.05 to
1.56"0.13 over the control. Both arachidonic acid and GTPg S-dependent stimulation were abolished in the presence of 10
mM amiloride. The non-metabolisable analogue of arachidonic acid, eicosa-5,8,11,14-tetraynoic acid also stimulated
conductive 22 Naq uptake. Furthermore, addition of indomethacin and nordihydroguairetic acid, inhibitors of cyclooxy-
genase and lipoxygenase pathways of arachidonate metabolism respectively, did not affect the arachidonic acid stimulation
q  .suggesting a direct effect of fatty acid upon the Na channel. Since mepacrine 50 mM , a phospholipase A inhibitor, did2
not affect the GTPg S-stimulated conductive 22 Naq uptake, and inhibition of G protein turnover by GDPb S did not
attenuate the arachidonic acid response, we conclude that these two regulatory pathways modulate alveolar Naq transport
directly and independently of each other.
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1. Introduction
Fluid absorption in the lung at birth is amiloride-
w xinhibitable 1 and the long-standing assumption that
Abbreviations: TRA, triethanolamine; GTPg S, guanosine 5X-
 .O- 3-thiotriphosphate ; bg-methylene-GTP-b , g-methylene-
X X guanosine 5 -triphosphate; GDPb S, guanosine 5 -O- 2-thio-
.diphosphate ; AA, arachidonic acid; ETYA, eicosa-5,8,11,14-te-
traynoic acid
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this process is a property of the alveolar epithelium is
supported by the recent discovery of an amiloride-
q  .sensitive Na channel in fetal alveolar type II ATII
w xpneumocytes 2 . By analogy with adult ATII cells
w x3 , it is likely that this channel is apically located in
fetal cells. The consensus model for Naq-dependent
fluid absorption in fetal lung is one in which the
conductive entry of Naq into ATII cells from the
lung lumen through Naq-selective channels, and its
subsequent extrusion across the basolateral mem-
brane via NaqrKq-ATPase, results in osmotically-
0167-4889r97r$17.00 Copyright q 1997 Elsevier Science B.V. All rights reserved.
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linked transepithelial movement of fluid. Therefore, it
is to be expected that factors which influence the
Naq channel activity of fetal ATII cells will affect
the efficiency of the fluid absorptive response at birth
and subsequent maintenance of the functional in-
tegrity of the lung postnatally.
In vivo studies indicate that development of the
lung fluid absorptive system in utero is under adrenal
steroid and thyroid hormone control and that circulat-
 .ing hormones principally epinephrine stimulate
q w xNa -dependent fluid absorption acutely at birth 4 .
More recent cellular and sub-cellular studies have
indicated the presence of regulatory factors, possibly
serving an autocrine or paracrine function, which are
apparently distinct from those pathways activated by
circulating hormones.
Two such factors are fatty acids and apically lo-
cated G proteins. Fatty acids have been shown to
modulate ion channel activity, either directly or via
w xmetabolites, in a number of systems 5 and it has
 .been recently demonstrated that arachidonic acid AA
can activate single Naq channels in excised mem-
w xbrane patches from fetal ATII cells 6 . G protein
regulation of epithelial Naq channels was first docu-
w xmented in the kidney 7 where later it was demon-
strated that part of the purified epithelial Naq chan-
w xnel was the G subunit 8 . Although G proteinia 3
subunits do not immunoprecipitate with the Naq
w xchannel complex from post-natal lung 9 , amiloride-
sensitive Naq channels in guinea-pig fetal ATII cells
w xhave been shown to be regulated by G proteins 2 .
Both G proteins and fatty acids have been shown
to produce their effects as a result of direct or indirect
interactions with their effectors. A direct action of
these stimulatory agents is one where the activated
Ga subunit or fatty acid acts on the channel protein
itself e.g. activation of skeletal muscle Ca2q channel
w x yby G a 10 or AA activation of Cl channels ins
w xairway 11 . Indirect activation of channels involves a
regulatory pathway with at least one intermediary
between stimulatory agent and effector e.g. G a-de-s
pendent activation of adenylyl cyclase resulting in
cAMP-dependent opening of CFTR Cly channels
w x q12 or AA activation of cardiac K channels by
w xmetabolites 13 .
This investigation was undertaken in order to study
the regulation of Naq channels in the apical mem-
brane of fetal alveolar epithelium by fatty acids and
G proteins and to test the hypothesis that these
membrane-delimited regulatory pathways are ar-
ranged in-series.
Part of this work has been presented in abstract
w xform 14 .
2. Methods
2.1. Solutions
Homogenisation medium: 250 mM sucrose, 10
 .mM TRA pH 7.6 ; containing 1.0 mg leupeptin, 1.0
 .mg pepstatin A, 4.0 mg 4- 2-aminoethyl -benzene-
 .sulfonylfluoride AEBSF , 2.6 mg aprotinin and 200
mg deoxyribonuclease I per 100 ml of medium.
Transport buffer: 125 mM NaCl, 10 mM TRA pH
.7.6 .
2.2. Preparation of apical membranes
Apical membranes were prepared from late gesta-
 .tion -3 days preterm fetal guinea-pig lung as
w xpreviously described 15 . Briefly, the lung lobes of
the fetus were excised at 2ndr3rd generation bronchi,
placed in ice-cold homogenisation medium and ho-
mogenised in a Waring blender followed by a Poly-
 .tron emulsifier 5 minr48C for both . After this,
differential centrifugation and Mg2q precipitation
were employed to yield an apically enriched mem-
brane fraction which was subsequently resuspended
in transport buffer and stored at y708C until used in
uptake experiments. All enzyme assays for various
.contaminant membranes were carried out as previ-
w xously described 15 . Protein was estimated by the
w xmethod of Bradford 16 , with bovine serum albumin
as the standard.
2.3. 22Naq uptake experiments
22 q Radioactive Na specific activity: 380 mCiP
y1.mg was used as a tracer for sodium. Membranes
were vesiculated by 20 passes through a 20 gauge
needle connected to a 1 ml syringe. The detailed
22Naq uptake protocol for measuring conductive
transport has been described recently by our group
w x15 and consequently is not extensively descibed
here. The procedure is based upon previously de-
w xscribed methods 17,18 . Briefly, NaCl-loaded vesi-
 .cles 125 mM are passed through a 1 ml Dowex
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50X8-100 column resulting in the imposition of an
outwardly-directed Naq gradient across vesicular
membranes upon resuspension in a low concentration
 .NaCl solution 125 mM . Such gradients result in a
negative intravesicular electrical diffusion potential
being established in those vesicles containing conduc-
tive Naq pathways, which in turn drives tracer 22Naq
uptake.
Uptake was examined as either a time-course or as
 w x.an initial rate at 2 min; 15 . At 2 min, or other
predetermined times in the case of time-courses, sam-
ples were taken from the reaction mixture and ap-
plied to individual Dowex columns in order to sepa-
rate intravesicular and extravesicular 22Naq. After
termination of the reaction, vesicles were eluted from
the Dowex columns and the eluent counted in a
Packard gamma counter to assess intravesicular
22Naq content. All data, unless otherwise stated,
 .represent gradient-stimulated conductive uptake and,
therefore, are not ‘contaminated’ by transport via
 q qe lec troneu tra l e .g ., N a r H -exchange ,
q q y . qNa :K :2 Cl -cotransport or electrogenic Na rso-
lute systems transport buffer contains no glucose or
. w xamino acids . Our previous observation 15 that out-
wardly-directed gradients of cations other than Naq
which are not substrates for the NaqrHq antiporter
amplify 22Naq uptake excludes exchange diffusion as
a possible mechanism of augmented uptake under
these conditions.
Each time-point was sampled in triplicate and,
unless a representative experiment is shown for clar-
ity, the data are presented as mean"S.E.M where
ns the number of separate vesicle preparations as-
. 22 q  .sayed . Intravesicular Na content uptake was
calculated as pmol 22NaqPmg proteiny1. Initial rate
experiments were calculated as a ratio of 22Naq
 . uptake at 2 min in the ‘test’ experiment e.g., in the
. 22 qpresence of a fatty acid to the Na uptake in the
 .appropriate vehicle control experiment and then
expressed as conductive 22 N aq uptake
 .observedrcontrol . Statistical analysis, where appro-
priate, was performed using the Student’s paired t
test.
2.4. Use of agonists and antagonists
GTPg S, bg-methylene-GTP and GDPb S were in-
corporated into membranes by vesiculating in trans-
port buffer containing a final concentration of 100
mM of a given guanosine nucleotide. After equilibra-
tion at room temperature for 1 h, an outwardly-di-
rected Naq gradient was imposed. An aliquot of
vesicles containing GTP or GDP analogue was then
22 q added to Na and uptake assessed at 2 min the
presence of GTPg S in the external medium was
.without effect . A similar approach of intravesicular
incorporation was adopted for indomethacin and
 .nordihydroguairetic acid NDGA when dissecting
the pathways involved in the arachidonic acid re-
sponse.
Fatty acids were dissolved in ethanol and diluted
 .in 250 mM mannitol, 10 mM TRA pH 7.6 to a final
concentration of 10 mM. The final concentration of
ethanol in the uptake experiments never exceeded
0.02%. Amiloride was dissolved in dimethylsulph-
 .oxide DMSO and treated in a similar fashion to
fatty acids. Vehicle control experiments were always
carried out and are defined as ‘control’ in the text and
figures.
2.5. Chemicals and materials
Fatty acids and ETYA were purchased from Cas-
cade Biochem Ltd, University Campus, Reading,
Berks., UK. Indomethacin and amiloride were sup-
plied by Calbiochem-Novabiochem, Nottingham, UK.
22Naq was bought from NEN-Dupont, Stevenage,
Herts., UK. AEBSF was purchased from ICN
Biomedicals, Thame, Oxon, UK. All other chemicals
were purchased from Sigma Chemicals, Poole, Dorset,
UK.
3. Results
3.1. Conducti˝e Naq uptake is regulated by G pro-
teins
 .The addition of GTPg S 100 mM , an irreversible
w xactivator of G proteins 19 , stimulated conductive
22Naq uptake with a time-course as shown in Fig.
1A. The regulation of 22Naq uptake by various mod-
ulators of G protein activity was characterised further
and a summary of the results shown in Fig. 1B. 100
mM GTPg S increased the initial rate of conductive
22 q Na uptake 1.35"0.02 fold above control, ns9;
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Fig. 1. Conductive 22Naq uptake is regulated by G proteins. A.
 .  .Membranes were vesiculated in the presence B or absence v
of 100 mM GTPg S in transport buffer and left to equilibrate at
room temperature for 1 h. After imposition of an outward Naq
gradient, 22Naq uptake was assessed at the given times. Conduc-
tive 22Naq uptake was calculated as 22Naq uptake in the
presence of a gradient minus 22Naq uptake in the absence of a
gradient for each time point. In this representative time-course
from a single membrane preparation, each point is the mean"
S.E.M. of triplicate samples. The absence of error bars at data
points, in this and subsequent figures, indicates that the error lies
within the symbol. Tracer 22NaCl concentrations350 nM here
and in all subsequent experiments. Inset: initial rate conditions
 .i.e., uptake at 2 min for this experiment. The difference be-
tween stimulated and control uptake is highly significant P -
.0.001 . B. Membranes were vesiculated in the presence of either
 .  .100 mM GTPg S ns9 , bg-methylene-GTP ns3 or GDPb S
 . qns8 as described. After equilibration and imposition of a Na
gradient, samples were taken in triplicate at 2 min both in the
presence and absence of a Naq gradient. Conductive 22Naq
uptake was determined as described in the text and is expressed
 .relative to the control value 1.00 . Each point represents the
mean"S.E.M. The number of experiments is given in parenthe-
ses.
) P -0.0001, )) P -0.001, ))) P -0.006. In this and all
other experiments n refers to the number of experiments per-
formed on different vesicle preparations.
.  .P-0.0001 . GDPb S 100 mM , an irreversible in-
w xhibitor of G protein turnover 19 , significantly re-
duced uptake from 1.00 to 0.79"0.04 ns8, P-
.0.006 compared to control . Recently, the existence
of a GTP-utilising kinase has been documented in
w xhuman airway epithelium 20 and we have observed
an equivalent phosphorylation pathway in lung ep-
ithelial apical membranes which are principally alve-
 .olar in origin unpublished observations . To test the
hypothesis that hydrolysis of GTP phosphorylation
.via a GTP-utilising kinase is a mechanism for the
stimulation of conductive 22Naq uptake, vesicles were
 .exposed to bg-methylene-GTP 100 mM , a GTP
analogue which cannot be hydrolysed by kinases
because of the presence of a methylene group be-
tween the b and g phosphates. Fig. 1B shows that
the level of 22Naq uptake stimulation to that which
was produced upon addition of 100 mM GTPg S is
similar to that observed in the presence of an equiva-
lent concentration of bg-methylene-GTP 1.31"0.05
.fold over control, ns3 suggesting that activation of
Naq channels with GTPg S occurs independently of
kinase-dependent GTP hydrolysis and subsequent
phosphorylation. Consisitent with the non-involve-
ment of G kinases in the response was the observa-
tion that the concurrent addition of GTPg S and bg-
methylene-GTP did not cause an additive effect Ta-
.ble 1 .
3.2. Fatty acid stimulation of conducti˝e Naq trans-
port
AA is a product of phospholipase action on plasma
membrane phospholipids. When applied at an extrav-
esicular concentration of 10 mM it stimulated con-
ductive 22Naq uptake to a degree similar to that seen
 .with 100 mM GTPg S Fig. 2A . Fig. 2B shows that
AA stimulation of conductive 22Naq uptake is com-
pletely abolished by 10 mM amiloride. This in-
hibitory effect of 10 mM amiloride was also observed
 .in the presence of 100mM GTPg S Table 1 which
clearly demonstrates that both G proteins and AA act
via stimulation of amiloride-sensitive channels.
 .AA is a polyunsaturated fatty acid PUFA and in
subsequent experiments we investigated whether other
categories of fatty acids, namely monounsaturated
 .  .MUFA and saturated SFA fatty acids, were able
to stimulate conductive 22Naq uptake into the mem-
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brane vesicles. Fig. 3 shows the effect of extravesicu-
lar addition of a range of fatty acids. The SFAs
 .  .  .myristic 14:0 , palmitic 16:0 and stearic 18:0
stimulated 22Naq uptake to a degree comparable to
 .the trans MUFA elaidic acid 18:1 , and PUFAs
 .  .arachidonic 20:4 and linoleic 18:2 acids. The two
MUFAs, elaidic and oleic acids, appear to exhibit a
difference with respect to the geometric conformation
of the double bond trans and cis isomeric forms,
.respectively ; the cis double bonded isomer is less
potent than the trans isomer. 10 mM of the methyl
ester of linoleic acid caused a stimulation of 22Naq
uptake. Although significant, it was only half as
 .effective as the non-esterified form. ETYA Fig. 3 is
an analogue of AA that possesses the same number
of carbon atoms but has four triple bonds instead of
the four double bonds of AA. This property of ETYA
results in it having the ability to inhibit AA-utilising
enzymes cyclooxygenase, lipoxygenase, and cy-
w xtochrome P-450 with varying affinities 21 as well
 ..as phospholipase A PLA . That ETYA itself can2 2
Table 1
Mean data from experimental manoeuvres described in the text
)Experimental manoeuvre Fractional uptake n
 .mean"S.E.M.
GTPg S 1.33"0.04 22
GTPg SqAmiloride 0.80"0.10 5
GTPg SqMepacrine 1.25"0.03 5
b ,g-methylene GTP 1.53"0.09 6
b ,g-methylene GTPqGTPg S 1.53"0.04 3
GDPb S 0.88"0.03 13
AA 1.46"0.06 21
AAqAmiloride 0.96"0.03 3
AAqIndomethacin 1.55"0.04 3
AAqNDGA 1.55"0.04 3
Amiloride 0.86"0.03 8
Mepacrine 0.90"0.04 5
Indomethacin 1.05"0.05 3
NDGA 1.10"0.04 3
Fractional uptake is the conductive 22Naq influx normalised to
 .its own control for each experiment observedrcontrol .
) Note that the n values for some of the maneouvres are
different from those quoted in the text and figure legends — this
is because the table includes all observations rather than merely
the paired controls for a particular set of experiments. For
example, the number of independent observations for the effect
of GDPb S of 13 represents ns8 in Fig. 1B plus ns5 in Fig.
5B.
Fig. 2. Conductive 22Naq uptake is amiloride-sensitive and
stimulated by arachidonic acid. A. Membranes were vesiculated
in transport buffer and a gradient imposed as described in Fig. 1
and the text. Vesicles were used immediately and exposed to
 .  .either 10 mM arachidonic acid v or the vehicle control B .
Conductive 22Naq uptake was calculated as in Fig. 1A. In this
representative time-course, each point is the mean"S.E.M. of
triplicate samples. B. Membranes were vesiculated as described
 . qin A . After imposition of an external facing Na gradient,
vesicles were pre-incubated for 1 min with 10 mM AA followed
.by 1 min in amiloride vehicle control or 10 mM amiloride
 .followed by 1 min in AA vehicle control or 10 mM AA
followed by 10 mM amiloride. 22Naq was then added and
uptake assessed at 2 min. Each point is the mean"S.E.M. ns3
.for all .
stimulate conductive 22Naq uptake suggests that cy-
clooxygenase and lipoxygenase pathways are not
necessarily involved in the stimulation of 22Naq
uptake. This conclusion is strengthened further by the
data shown in Fig. 4. AA stimulation 1.55"0.03-
.fold over control; ns3 was still observed in the
presence of 10 mM indomethacin INDO; 1.55"
.0.04-fold over control; ns3 and 10 mM nordihy-
droguaiaretic acid NDGA; 1.55"0.04 fold over
.control; ns3 alone. AA stimulation when both
INDO and NDGA were present together was 1.51"
 .0.07 ns3 above the control. The observation that
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Fig. 3. Saturated, monounsaturated and polunsaturated fatty acids
stimulate conductive 22Naq uptake. Membranes were treated as
described in Fig. 1 and text. After 1 h, an external facing Naq
gradient was imposed by placing the vesicles in a low Naq
medium containing 10 mM of a given fatty acid. 22Naq uptake
was assessed at 2 min. All differences are compared to the
 .vehicle control. Key to figure: MA, myristate ns3 ; PA, palmi-
 .  .  .tate ns3 ; SA, stearate ns5 ; EA, elaidate ns5 ; OA,
 .  .oleate ns3 ; LA, linoleate ns10 ; mLA, methyllinoleate
 .  .ns5 ; AA, arachidonate ns10 ; ETYA, eicosa-5,8,11,14-te-
 .traynoic acid ns5 . MUFA, monounsaturated fatty acid; t,
trans isomer; c, cis isomer; PUFA, polyunsaturated fatty acid;
X:Y-X, number of carbon atoms per chain and Y, number of
double bonds. The numbers in parentheses correspond to the
number of experiments for that compound.
AA stimulation of the Naq conductance is observed
in the presence of these compounds suggests that its
mode of action is direct.
Fig. 4. Arachidonic acid stimulation of conductive 22Naq uptake
is independent of cyclooxygenase and lipoxygenase pathways.
Membranes were vesiculated in either 125 mM NaClr10 mM
 .TRA pH 7.6 or 125 mM NaClr10 mM TRA containing either
 .  .10 mM arachidonic acid AA , 10 mM indomethacin IND , 10
 .mM nordihydroguaiaretic acid NDGA , alone or in combination.
After equilibration at room temperature for 1 hour, initial rate of
22 q  .conductive Na uptake was assessed at 2 min . Each point is
 .the mean"S.E.M. ns3 for all .
3.3. GTPgS probably stimulates conducti˝e Naq up-
take ˝ia a direct G protein-channel interaction
G proteins have been shown to regulate PLA 2
resulting in G protein-dependent production of AA
w xfrom membrane phospholipids 22,23 . In renal ep-
ithelial cells, G protein stimulation of PLA ulti-2
mately leads to Naq channel activation via the
w xmetabolism of AA by the lipoxygenase pathway 24 .
However, the results shown in Fig. 5A suggest that
this may not be the case in lung. 50 mM mepacrine, a
specific PLA inhibitor at this concentration, failed2
to affect significantly the GTPg S-stimulated 22Naq
uptake 1.25"0.03-fold over control in presence of
Fig. 5. AA and G protein-stimulation of 22Naq uptake operate in
parallel. A. Membranes were vesiculated in transport buffer
containing either 100 mM GTPg S, 50 mM of the PLA in-2
hibitor, mepacrine, or 100 mM GTPg S plus 50 mM mepacrine.
After establishment of Naq gradients, 22Naq uptake was as-
sessed after a 2-min incubation in aliquots of individual vesicle
preparations with 100 mM GTPg S or 50 mM mepacrine or
.both . Each point is the mean"S.E.M. of 5 experiments. B.
Membranes were vesiculated in transport buffer in the presence
and absence of 100 mM GDPb S. After Naq gradients were
established, aliquots of individual vesicle preparations, with and
without 100 mM GDPb S, were exposed to 10 mM arachidonic
acid or ethanol control. 22Naq uptake was assessed at 2 min.
Each point is the mean"S.E.M. of 5 experiments. ) P -0.731;
)) P -0.04.
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mepacrine compared to 1.38"0.07 in its absence;
.ns5; P-0.116 implicating a role for direct G
protein-channel interactions rather than G protein
modulation of PLA . The possibility of a role for2
PLA in the tonic stimulation of Naq channels has2
not been ruled out since 50 mM mepacrine alone
22 q inhibited unstimulated conductive Na uptake Fig.
.5A . This suggests that there may be a basal turnover
of PLA at the apical membrane. The involvement of2
phospholipases C andror D were not addressed in
this study but do, nevertheless, remain a possibility.
3.4. Arachidonic acid stimulation of conducti˝e Naq
uptake is still obser˝ed in the presence of GDPbS
In this series of experiments, 100 mM GDPb S
again significantly reduced conductive 22Naq uptake
 .0.91"0.03 of control level; ns5; P-0.04 . Stim-
ulation of conductive 22Naq uptake by AA persisted
in the presence of 100 mM GDPb S 1.65"0.11-fold
.over control; ns5; Fig. 5B . The level of stimula-
tion observed was comparable to that when 10 mM
arachidonic acid was added alone 1.68"0.06, ns5;
.P-0.731 which suggests that arachidonic acid
stimulation of conductive 22Naq uptake can occur
independently of the G protein-dependent activation
pathway.
A summary of the pooled mean data for many of
the experimental manoeuvres is presented, for ease of
comparison, in Table 1.
4. Discussion
4.1. Channel identity
The molecular identity of the alveolar amiloride-
sensitive channel has been strongly debated since the
q  .cloning of an epithelial Na channel ENaC from rat
w xcolon 25 . There is little doubt about the importance
of the a-subunit of ENaC to the fluid reabsorption at
birth since a-ENaC-deficient mice rapidly develop
respiratory distress and die within 40 h of delivery
w x26 . Although we have detected a- and b-ENaC
mRNA by Northern blot and reverse transcriptase
polymerase chain reaction unpublished observations,
.D.L. Baines, P.J. Kemp and R.E. Olver , we observe
only a moderately Naq selective, amiloride-sensitive
channel in isolated fetal ATII cells by patch-clamp
w x2 ; the biophysical and pharmacological properties of
this channel suggests strongly that it underlies the
amiloride-senstive Naq flux which we measure in the
 w x .apical membrane vesicles see 27 for a review . As
the characteristics of Naq channels are known to
depend heavily on the preparation, species, culture
conditions, developmental stage and the age of the
w xchannel in the membrane 28,29 it seems likely that
the channel which we record represents a species-,
gestation- or preparation-dependent phenotype of
ENaC. In support of this view are our preliminary
Northern blot data which suggest that ENaC subunit
ontogeny in the developing guinea-pig alveolar ep-
ithelium is different from that demonstrated in the rat
w x30 .
4.2. G protein regulation of conducti˝e Naq uptake
The role of G proteins in the regulation of ion
channels is well established and, in epithelial tissues,
best characterised in kidney. Although less exten-
sively studied, there is evidence for fatty acid modu-
lation of conductive membrane transport in a number
of systems e.g. suppression of Naq currents in squid
w x qgiant axon 31 , activation of K channels in gastric
w xsmooth muscle 32 . Our observation that conductive
Naq uptake is modulated by intravesicular incorpora-
tion of irreversible G protein activators and inactiva-
 .tors Fig. 1 confirms our previous electrophysiologi-
cal data in excised patches and, for the first time,
provides evidence for the co-localisation of the G
 . q  .protein s and associated Na channel s in the apical
membrane of fetal ATII cells. Abolition of the GTPg S
 .stimulation by amiloride Table 1 suggests that the
entire G protein-stimulated conductive Naq transport
occurs via amiloride-sensitive pathways.
In a previous study of renal epithelial Naq chan-
w xnels 24 , it was demonstrated that GTPg S stimula-
tion of Naq channel activity could be inhibited by the
 .PLA inhibitor mepacrine at 50 mM and that the2
block could be overcome by the addition of either
AA or exogenous G subunit. Furthermore, Naqi a 3
channel activation by either GTPg S, AA or exoge-
nous G subunit was inhibited by addition ofia 3
NDGA-indicating that the lipoxygenase pathway is
required for channel activation. In contrast to these
findings, we have observed that GTPg S activation of
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alveolar epithelial channels is not affected by the
 .addition of 50 mM mepacrine Fig. 5A . We there-
fore suggest that the apically located signal transduc-
tion pathway does not involve G protein stimulation
of PLA but may be the result of direct G protein2
activation of the Naq channel. Currently we are
attempting to establish which particular G protein
a-subunits are co-localised with the Naq channel in
the apical membrane of ATII cells using Western
blotting. Preliminary evidence suggest enrichment of
 .G , G and G as well as G isotype unknowni1 i2 i3 o
w x33 .
4.3. Fatty acid stimulation of conducti˝e Naq uptake
As shown in Fig. 2, the addition of 10 mM
extravesicular AA stimulates conductive Naq uptake.
That a significant difference in vesicular 22Naq con-
tent can be seen within one minute of the start of the
assay representing also one minute of AA presenta-
.tion to the membrane , demonstrates that AA action
is rapid and suggests that it probably interacts with
the Naq channel itself. This initial observation led us
to test the specificity of this effect on conductive
Naq uptake. As can be seen in Fig. 3, all classes of
fatty acids were able to stimulate Naq uptake. The
addition of either 10 mM extravesicular myristic,
 .  .palmitic, stearic all SFA , elaidic a MUFA , linoleic
 . qor AA both PUFAs stimulated conductive Na
uptake to a similar degree, suggesting a metabolite-
independent effect; this direct activation is not depen-
dent upon the degree of fatty acid saturation. The
difference between cis and trans isomers oleic and
.elaidic respectively; Fig. 3 suggests that conforma-
tion is important and that a specific binding domain
 .on the channel or associated protein may be in-
volved in the fatty acid response. Ion channel modu-
lation has been observed when the fatty acid has been
applied either extracellularly and intracellularly
w x31,32 suggesting that in these preparations there
may be a fatty acid interaction site on the channel
which is located within the membrane. However, in
other instances of fatty acid ion channel modulation,
only cytosolic application of fatty acid exerted an
w xeffect 11 . It has also been suggested that membrane
lipid composition may be an important determinant
w xof channel activity 34 . Although fatty acids have
been shown to affect ion channels by altering mem-
brane fluidity only at high concentrations up to 2
. w xmM 35 , this seems an unlikely mode of action at
 .the concentrations used here 10 mM . Furthermore,
since the ability of fatty acids to stimulate uptake
appears independent of their partition into the bilayer
compare, for example, the stimulation with stearic,
oleic and arachidonic acids which have partition co-
w x.efficients in the ratio of 26:5:1 respectively 36 we
suggest that solution in the membrane is not a pre-
requisite for their biological effects.
The observation that methyllinoleic acid has a
smaller effect on conductive Naq uptake than linoleic
 .acid Fig. 3 , combined with our previously docu-
mented evidence that the channel pore has a high
field-strength resulting from a large negative charge
. w xin or close to the mouth of the channel 15 supports
the hypothesis that the fatty acid interaction site is
localised to the non-conductive domains of the pro-
tein; i.e. if the interaction were close to the pore, we
would predict that the negatively charged linoleic
acid would be a less effective activator of conductive
Naq uptake than its uncharged methyl ester. Burt
proposed such a mechanism of action for the effect of
dooxyl stearic acid upon the gap junction of cardiac
w xcells 37 .
4.4. Metabolite-independent stimulation of conducti˝e
Naq uptake by AA
There are multiple pathways for the oxidative
w x  Xmetabolism of AA 38 . The lipoxygenases 5 and
X.3 lead initially to hydroperoxyeicosatetraenoic acids,
which in turn are converted to leukotrienes, lipoxins
and hepoxilins. Cyclooxygenase action upon AA ulti-
mately leads to the production of prostaglandins,
thromboxanes and prostacyclin. Cytochrome P450
utilises AA to produce fatty acid alcohols and epox-
ides. Many of these metabolic products having been
documented as regulators of cell function.
The use of apical plasma membrane vesicles has
allowed us to study conductive 22Naq uptake in
isolation from the rest of the cell. We have previously
w xdemonstrated the purity of the vesicles 15 which are
not enriched in intracellular membrane bound en-
zymes or cytosolic enzymes such as cytochrome P450,
which has been demonstrated to have an intracellular
( )G.K. Fyfe et al.rBiochimica et Biophysica Acta 1355 1997 33–42 41
w xlocation in various alveolar cell types 39,40 . Evi-
dence for a direct effect of fatty acids upon Naq
channels can be seen in both Fig. 3 and Fig. 4. Fig. 3
shows that fatty acids which are not substrates of the
enzymes in the AA metabolic cascade cause a stimu-
lation of conductive Naq uptake. It also shows that
ETYA, an AA analogue that inhibits all the enzymes
in the AA cascade to varying degree, can itself
q  .stimulate conductive Na uptake. Our data Fig. 4
showing that AA stimulation of conductive Naq
uptake is still observed in the presence of the more
specific cyclooxygenase and lipoxygenase inhibitors,
indomethacin and NDGA, strengthens further the case
for a direct effect of AA, and the other fatty acids, on
Naq channels. Modulation of other ion channels by
AA in the presence of AA metabolising enzyme
w xinhibitors has also been reported 11,41 .
Taken together, the data presented in Fig. 5B
 qwhich shows that AA can still activate the Na
.conductance in the presence of GDPb S and our
recent findings that only unsaturated fatty acids mod-
ulate G protein turnover in lung apical membrane
w x q42 suggest that fatty acid regulation of Na conduc-
tance involves two overlapping systems. The first can
be activated by fatty acids of differing carbon back-
bone length and degree of saturation and is indepen-
.dent of G proteins whilst the other is an exclusive
property of unsaturated fatty acids and occurs via G
q .protein modulation of Na channels .
4.5. Concluding remarks
We have extended our initial observations of an
apically located Naq conductance in fetal ATII cells
and shown that it is modulated both fatty acids and G
proteins; these parallel pathways of activation may
result from a direct interaction with the channel
 . qprotein s . The regulation of epithelial Na channels
in the apical membrane of the alveolar epithelium by
both these mechanisms appears to be different from
that shown in renal epithelial Naq channels where
 .only the one PLA dependent pathway of activation2
exists and compliments results from our previous
w xsingle channel studies 27 . We speculate that this
difference may reflect either a difference in channel
 .protein composition e.g., different subunits or a
difference in G protein class or other associated
regulatory proteins.
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